The text discusses the limitations of the Amsterdam II criteria for identifying patients with Lynch syndrome and proposes less restrictive criteria, including clinical and molecular markers, for investigating the syndrome. Testing for microsatellite instability in tumor cells can help identify individuals predisposed to Lynch syndrome.